Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Altria-Juul Labs deal: why did it occur and what does it mean for the US nicotine delivery product market, Tobacco Control, September 2019, BMJ,
DOI: 10.1136/tobaccocontrol-2019-055081.
You can read the full text:
Contributors
The following have contributed to this page